Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Other financing activities (2020 - 2023)

NeuroPace (NPCE) has 4 years of Other financing activities data on record, last reported at $186000.0 in Q4 2023.

  • For Q4 2023, Other financing activities fell 46.4% year-over-year to $186000.0; the TTM value through Sep 2024 reached $186000.0, down 60.09%, while the annual FY2023 figure was $305000.0, 12.1% down from the prior year.
  • Other financing activities reached $186000.0 in Q4 2023 per NPCE's latest filing, up from $9000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.8 million in Q2 2021 and bottomed at -$117000.0 in Q3 2020.
  • Average Other financing activities over 4 years is $472666.7, with a median of $186000.0 recorded in 2023.
  • Peak YoY movement for Other financing activities: surged 1447.01% in 2021, then crashed 46.4% in 2023.
  • A 4-year view of Other financing activities shows it stood at $210000.0 in 2020, then skyrocketed by 761.9% to $1.8 million in 2021, then crashed by 80.83% to $347000.0 in 2022, then tumbled by 46.4% to $186000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $186000.0 in Q4 2023, $9000.0 in Q2 2023, and $110000.0 in Q1 2023.